2015 Milan Declaration: A Call to Action on Obesity - an EASO Position Statement on the Occasion of the 2015 EXPO by G. Fr&#252 et al.
 © 2016 The Author(s)
Published by S. Karger GmbH, Freiburg 
 Clinical Information 
 Obes Facts 2016;9:296–298 
 2015 Milan Declaration: A Call to Action on 
Obesity – an EASO Position Statement on the 
Occasion of the 2015 EXPO 
 Gema Frühbeck a, b    Paolo Sbraccia a, c, d    Enzo Nisoli a, c, e    
Euan Woodward a    Volkan Yumuk a, f    Nathalie J. Farpour-Lambert a, g    
Jason G.C. Halford a, h    Hermann Toplak a, i    Michele O. Carruba a, c, j  
 a  European Association for the Study of Obesity,  London , UK;  b  Department of 
Endocrinology & Nutrition, Clínica Universidad de Navarra, University of Navarra, 
IdiSNA, CIBEROBN, Instituto de Salud Carlos III,  Pamplona , Spain;  c  Società Italiana 
dell’Obesità",  Rome , Italy;  d  Department of Systems Medicine, University of Rome ‘Tor 
Vergata’ and Obesity Center, University Hospital Policlinico Tor Vergata,  Rome , Italy; 
 e  Department of Medical Biotechnology and Translational Medicine, Center for Study 
and Research on Obesity, University of Milan,  Milan , Italy,  f  Division of Endocrinology, 
Metabolism & Diabetes, Istanbul University Cerrahpasa Medical Faculty,  Istanbul , Turkey;  
g  Obesity Prevention and Care Program, Service of Therapeutic Education for Chronic 
Diseases, Department of Community Health, Primary Care and Emergency, University 
Hospital of Geneva and University of Geneva,  Geneva , Switzerland;  h  Department of 
Psychological Sciences, University of Liverpool,  Liverpool , UK;  i  Department of Internal 
Medicine, Medical University Graz,  Graz , Austria;  j  Department of Pharmacology, 
Chemotherapy and Medical Toxicology, Center for Study and Research on Obesity, 
School of Medicine, Milan University, Istituto Auxologico Italiano,  Milan , Italy
 
 Back to the Future 
 In June 1999 preceded by a ‘Fanfara dei Bersaglieri’, a special task force of the Italian 
army, that seeked to emphasize and symbolize the announcement of a relevant action against 
obesity, the European Association for the Study of Obesity (EASO) issued the ‘Milan Decla-
ration’ at the 9th European Congress on Obesity (ECO) held in that city calling for recognition, 
support, and national action to combat the obesity epidemic. Although in the intervening 
years substantive progress has been made, our current best remains not good enough, and 
both new resources and opportunities need to be harnessed and exploited in earnest. With 
the conviction that experts cannot merely sit back to watch the problem of, and the problems 
resulting from, obesity unfold  [1, 2] , EASO together with the Italian Society of Obesity  (SIO) 
presented on June 6 the ‘2015 Milan Declaration’ at the EXPO (Universal Exposition topic 
Feeding the Planet, Energy for Life) restating that it is time to act (Annex 1, available at  http://
www.karger.com/ProdukteDB/produkte.asp?doi=448234 )  [3] . Within this, EASO resolves to 
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provide leadership, guidance, and support to governments, as part of its mission of facilitating 
and engaging in actions to reduce the burden of unhealthy excess weight in Europe.
 Obesity as a gateway to a multitude of disabling and fatal diseases  [4] threatens not only 
global health care systems but also has the potential to cripple national economies and global 
development. Thus, obesity must become a top priority across governments; only a multi-
modal strategy that favors an increased commitment for concerted, coordinated, and specific 
actions will yield tangible results. To effectively combat the obesity epidemic a more pro-
active approach is needed. At this stage, to develop and implement programs for prevention, 
early diagnosis, and treatment is absolutely mandatory  [5–11] . Therefore, immediate action 
and priority for research, innovation, and action should focus on obesity, as both a non-
communicable disease (NCD) itself (not yet universally recognized) and a gateway to type 2 
diabetes and other very serious NCDs (now commonly accepted)  [2, 12–15] .
 Taking the Patient View into Consideration 
 While in many areas of medicine the participation of patients is encouraged, traditionally 
those who are overweight or have obesity have been excluded. In 2015 the EASO Patient 
Council expressed their view which emphasized the social dimension of obesity. The council 
called for respect, acceptance, recognition, and impartial discussion along with shared respon-
sibility to stop further stigmatization of those with obesity (Annex 2, available at  http://www.
karger.com/ProdukteDB/produkte.asp?doi=448234 ). Patients want to be involved in the 
process of obesity-related research, management, and development throughout society. This 
does not undermine the role of the individual but rather empowers him/her through 
ownership of the solution as well as the problem. Partnership agreements that are closer to 
the needs of the individuals and communities are long overdue. Regulatory authorities should 
incorporate the patient perspective highlighting the need to build and maintain a long-term 
support system around the individual, including integrated networks of key professionals 
providing relevant and sufficient help and support.  
 Whereas numerous studies highlight the relevance of sociocultural factors influencing 
incidence and prevalence of obesity, few interventions address situational rather than indi-
vidual factors and also how people with obesity perceive causes of and solutions to their 
condition. In this context, more attention has to be paid to the interplay between the biomedical 
aspects and social/situational dimensions of obesity. By labelling obesity a disease, we make 
it a priority and to some extent address stigmatization, but we cannot escape its societal and 
environmental causes, otherwise failure remains at hand. The solutions to obesity are to be 
found within the society and in individuals with obesity, and not merely by physicians. With 
the paucity of available tools for physicians to combat obesity, regulatory authorities must 
recognize the environmental as well as biological barriers to treatment success. This requires 
the inclusion of environmental as well as individual considerations into any thorough risk-
benefit analyses of treatment options or evaluation of policy intervention. Not least educa-
tional efforts should be assumed by overall society to promote sobriety in food consumption 
and to avoid food wastefulness. These actions could tackle partly the persuasive and imposing 
advertisements for food overconsumption. The next 15 years will be a critical period for 
applying our knowledge, and especially for testing our collective ability to limit the spread 
and impact of obesity in a way we have failed to since 1999. A major concern that recurs 
throughout these years, is the rapid spread of obesity among young children  [16–18] . A 
comprehensive multi-stakeholder approach requires a truly successful portfolio of interven-
tions (from prevention to treatment), within a whole population approach, that directly 
addresses fundamental causes of obesity. Only this will provide the basis for an effective part-
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nership that should at last contain the global spread of obesity and effectively manage its 
consequences. A Milan 2030 declaration should then not be necessary.
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